Leveraging IRT for Clinical Trials with Radionuclide Products

Irenea Seredina, Executive Director at S-CLINICA
Jasvinder Osan, VP - Business Development at S-CLINICA

Leveraging IRT for Clinical Trials with Radionuclide Products

Click to play video

Case study insight into trial: disease area, phase, the rationale for flexibility etc
Details on practicalities, challenges of the trial
Insight into how IRT was leveraged to hold the study / do something innovative

Speakers

Irena Seredina’ background is medicine, economics and management. She holds an MD, honors diploma and a MSc in Health Economics. During her medical practice, Seredina worked in clinical research as an investigator. The results of her research were published in a number of articles and presented at several international conferences. She continued her career as a health economist and in 2004, Seredina joined S-Clinica, first in business and then as the Head of Operations. She is currently responsible for the strategic business relationships.

Jas started his career in the 90s, as a data manager within clinical trials when these were done predominantly on paper - and has over the years seen the industry change and evolve. He has a degree in Applied Physics, and has worked over the last 25 years within eClinical technologies and solutions. Jas's role within S-CLINICA is to bring new business, and build strategic relationships with customers.